Ensign Peak Advisors’s National Healthcare NHC Stock Holding History

Ensign Peak Advisors’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-740	Closed	-$47K	–	2073
2022 Q3	$47K	Buy	+740	New	+$51.4K	﹤0.01%	2221

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ensign Peak Advisors's NHC Position: Q4 2022 in Review

Ensign Peak Advisors sold out of National Healthcare (NHC) in Q4 2022, closing a stake of 740 shares — an estimated $47K sold.

Ensign Peak Advisors first reported a position in NHC in Q3 2022 and held it in 1 quarter. The position peaked at $47K in Q3 2022. 118 funds tracked by Wall St. Rank hold NHC as of Q4 2022.

Ensign Peak Advisors reported no remaining National Healthcare position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 740 National Healthcare shares in Q4 2022, an estimated $47K.
Ensign Peak Advisors first reported a position in National Healthcare in Q3 2022 and held it in 1 quarter.
Ensign Peak Advisors's National Healthcare position peaked at $47K in Q3 2022.
118 funds tracked by Wall St. Rank held National Healthcare as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.